Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
67 /100
HIGH RISK
Score updated Aug 28, 2026

IBO — Impact BioMedical Inc. Dilution Risk Tracker

Track IBO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IBO — Get alerts when the score changes →

As of August 28, 2026, Impact BioMedical Inc. (IBO) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. Impact BioMedical Inc. has a market capitalization of $56.07M, 107.82M shares outstanding, 22 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
75
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 70%
• 50-day avg $0.62 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (67/100)
🔔 Track IBO — Get forecast alerts →

Market Data

Market Cap$56.07M
Shares Outstanding107.82M
Float11.44M
Cash$20.0K
Debt$11.90M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 209.1% shares (2026Q1 vs prior)
22 institutional holders · 4.45M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.42M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 1.19M shares
#3 STATE STREET CORP 607.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest554.9K
Days to Cover27.1
% of Float4.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track IBO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IBO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IBO
IBO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.